The Valley Desk

NCT04300296 · Interventional trial

PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus

Overall registry status Completed

Phase 2

Conditions Lichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen Planopilaris

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov